Quality of life in psoriatic arthritis

References

• WHOQOL Group. Development of the WHOQOL: rational and current status. Int J Mental Health. 1994;23:24–56.
   Web of Science ®Google Scholar
• World Health Organization. WHOQOL-BREF introduction, administration, scoring and generic version of the assessment. Geneva: World Health Organization; 1996.
   Google Scholar
• World Health Organization. International Classification Of Functioning, disability and health (ICF) [Internet]; [cited 2017 Dec 2]. Available from: www.who.int/classifications/icf/en/
   Google Scholar
• Strand V, Singh JA. Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs. 2010;70:121–145.
   PubMed Web of Science ®Google Scholar
• Singh JA, Strand V. Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009;36:1012–1020.
   PubMed Web of Science ®Google Scholar
• Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol. 2001;28:1842–1846.
   PubMed Web of Science ®Google Scholar
• Husted JA, Gladman DD, Farewell VT, et al. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001;45:151–158.
   PubMed Web of Science ®Google Scholar
• Borman P, Toy GG, Babaoglu S, et al. A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis. Clin Rheumatol. 2007;26:330–334.
   PubMed Web of Science ®Google Scholar
• Ovayolu N, Ovayolu O, Karadag G. Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy ındividuals. Clin Rheumatol. 2011;30:655–664.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Sarzi-Puttini P, Girolimetti R, et al. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol. 2009;27(5 Suppl 56):S67–S74.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Carotti M, Gasparini S, et al. The health related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcome. 2009;7:25.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14–7.
   PubMed Web of Science ®Google Scholar
• Strand V, Sharp V, Koenig AS, et al. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis. 2012;71:1143–1150.
   PubMed Web of Science ®Google Scholar
• Taylor WJ. Impact of psoriatic arthritis on the patient: through the lens of the WHO international classification of functioning, health, and disability. Curr Rheumatol Rep. 2012;14:369–374.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Mease PJ, Strand V, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol. 2007;34:1167–1170.
   PubMed Web of Science ®Google Scholar
• Orbai AM, de Wit M, Mease P, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673–680.
   PubMed Web of Science ®Google Scholar
• Gudu T, Kiltz U, de Wit M, et al. Mapping the effect of psoriatic arthritis using the international classification of functioning, disability and health. J Rheumatol. 2017;44:193–200.
   PubMed Web of Science ®Google Scholar
• Tillett W, Adebajo A, Brooke M, et al. Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep. 2014;16:418.
   PubMed Web of Science ®Google Scholar
• Stamm TA, Nell V, Mathis M, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum. 2007;57:487–494.
   PubMed Web of Science ®Google Scholar
• Moverley AR, Vinall-Collier KA, Helliwell PS. It’s not just the joints, it’s the whole thing: qualitative analysis of patients’ experience of flare in psoriatic arthritis. Rheumatology. 2015;54:1448–1453.
   PubMed Web of Science ®Google Scholar
• Dures E, Hewlett S, Lord J, et al. Important treatment outcomes for patients with psoriatic arthritis: a multisite qualitative study. Patient. 2017;10:455–462.
   PubMedGoogle Scholar
• Szentpetery A, Johnson MA, Ritchlin CT. GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 annual meeting. J Rheumatol. 2014;41:1200–1205.
   PubMed Web of Science ®Google Scholar
• Gossec L. Remission and flare in psoriatic arthritis: a prospective 6-month study with a double perspective (ReFlaP). 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT03119805?term=NCT03119805&rank=1 (Identification No NCT03119805)
   Google Scholar
• Gossec L, de Wit M, Kiltz U, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012–1019.
   PubMed Web of Science ®Google Scholar
• McKenna SP, Doward LC, Whalley D, et al. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004;63:162–169.
   PubMed Web of Science ®Google Scholar
• Torre-Alonso JC, Gratacos J, Rey-Rey JS, et al. Development and validation of a new instrument to measure health-related quality of life in patients with psoriatic arthritis: the VITACORA-19. J Rheumatol. 2014;41:2008–2017.
   PubMed Web of Science ®Google Scholar
• Boers M, Kirwan JR, Wells G, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014;67:745–753.
   PubMed Web of Science ®Google Scholar
• de Wit MP, Berlo SE, Aanerud GJ, et al. European league against rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis. 2011;70:722–726.
   PubMed Web of Science ®Google Scholar
• Kalyoncu U, Ogdie A, Campbell W, et al. Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open. 2016;2:e000217.
   PubMedGoogle Scholar
• Palominos PE, Gaujoux-Viala C, Fautrel B, et al. Clinical outcomes in psoriatic arthritis: a systematic literature review. Arthritis Care Res (Hoboken). 2012;64:397–406.
   PubMed Web of Science ®Google Scholar
• Taylor WJ, Mease PJ, Adebajo A, et al. Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health. J Rheumatol. 2010;3:1885–1891.
   Google Scholar
• Stucki G, Cieza A, Geyh S, et al. ICF core sets for rheumatoid arthritis. J Rehabil Med. 2004;44(Suppl):87–93.
   PubMedGoogle Scholar
• Boonen A, Braun J, van der Horst Bruinsma IE, et al. ASAS/WHO ICF core sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis. 2010;69:102–107.
   PubMed Web of Science ®Google Scholar
• Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology (Oxford). 2012;51:275–283.
   PubMed Web of Science ®Google Scholar
• Tillett W, Shaddick G, Askari A, et al. Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. Rheumatology (Oxford). 2015;54:157–0162.
   PubMed Web of Science ®Google Scholar
• Kennedy M, Papneja A, Thavaneswaran A, et al. Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis. Clin Exp Rheumatol. 2014;32:342–348.
   PubMed Web of Science ®Google Scholar
• Walsh JA, McFadden ML, Morgan MD, et al. Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol. 2014;41:1670–1674.
   PubMedGoogle Scholar
• Siannis F, Farewell VT, Cook RJ, et al. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis. 2006;65:478–481.
   PubMedGoogle Scholar
• Hu SW, Holt EW, Husni ME, et al. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study. Semin Arthritis Rheum. 2010;39:384–397.
   PubMed Web of Science ®Google Scholar
• Putrik P, Ramiro S, Hifinger M, et al. In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study. Ann Rheum Dis. 2016;75:715–720.
   PubMed Web of Science ®Google Scholar
• Freire M, Rodriguez J, Moller I, et al. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics [Spanish]. Reumatol Clin. 2011;7:20–26.
   PubMedGoogle Scholar
• Khraishi M, MacDonald D, Rampakakis E, et al. Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol. 2011;30:877–885.
   PubMed Web of Science ®Google Scholar
• Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res. 2011;63:1729–1735.
   PubMed Web of Science ®Google Scholar
• Kotsis K, Voulgari PV, Tsifetaki N, et al. Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res. 2012;64:1593–1601.
   PubMed Web of Science ®Google Scholar
• McDonough E, Ayearst R, Eder L, et al. Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol. 2014;41:887–896.
   PubMed Web of Science ®Google Scholar
• Bandinelli F, Prignano F, Bonciani D, et al. Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). Clin Exp Rheumatol. 2013;31:318–319.
   PubMed Web of Science ®Google Scholar
• Schmitt J, Ford DE. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach. Gen Hosp Psychiatry. 2007;29:134–140.
   PubMed Web of Science ®Google Scholar
• Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76:1906–1910.
   PubMed Web of Science ®Google Scholar
• Betteridge N, Boehncke WH, Bundy C, et al. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol. 2016;30:576–585.
   PubMed Web of Science ®Google Scholar
• Uttjek M, Nygren L, Stenberg B, et al. Marked by visibility of psoriasis in everyday life. Qual Health Res. 2007;17:364–372.
   PubMed Web of Science ®Google Scholar
• Husted JA, Tom BD, Schentag CT, et al. Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis. 2009;68:1553–1558.
   PubMed Web of Science ®Google Scholar
• Gudu T, Etcheto A, de Wit M, et al. Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine. 2016;83:439–443.
   PubMed Web of Science ®Google Scholar
• Husted JA, Tom BD, Farewell VT, et al. Longitudinal analysis of fatigue in psoriatic arthritis. J Rheumatol. 2010;37:1878–1884.
   PubMedGoogle Scholar
• Carneiro C, Chaves M, Verardino G, et al. Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. Clin Cosmet Investig Dermatol. 2017;10:155–163.
   PubMed Web of Science ®Google Scholar
• Tezel N, Yilmaz Tasdelen O, Bodur H, et al. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Int J Rheum Dis. 2015;18:63–69.
   PubMed Web of Science ®Google Scholar
• Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford). 2012;51:571–576.
   PubMed Web of Science ®Google Scholar
• Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80:430–434.
   PubMed Web of Science ®Google Scholar
• Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic quality of life study. Acta Derm Venereol. 2002;82:108–113.
   PubMed Web of Science ®Google Scholar
• Krueger G, Koo J, Lebwohl M, et al. The impact of Ps on quality of life: results of a 1998 National Ps Foundation patient-membership survey. Arch Dermatol. 2001;137:280–284.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14:241–242.
   PubMed Web of Science ®Google Scholar
• Kurd SK, Troxel AB, Crits-Christoph P, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis. A population-based cohort study. Arch Dermatol. 2010;146:891–895.
   PubMed Web of Science ®Google Scholar
• Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383–392.
   PubMed Web of Science ®Google Scholar
• de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001;144:33–36.
   PubMed Web of Science ®Google Scholar
• Ciocon DH, Horn EJ, Kimball AB. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only. Am J Clin Dermatol. 2008;9:111–117.
   PubMed Web of Science ®Google Scholar
• Shah K, Paris M, Mellars L, et al. Real-world burden of comorbidities in US patients with psoriatic arthritis. RMD Open. 2017;3:e000588.
   PubMed Web of Science ®Google Scholar
• Sobchak C, Eder L. Cardiometabolic disorders in psoriatic disease. Curr Rheumatol Rep. 2017;19:63.
   PubMed Web of Science ®Google Scholar
• Husted JA, Thavaneswaran A, Chandran V, et al. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol. 2013;40:1349–1356.
   PubMed Web of Science ®Google Scholar
• European League Against Rheumatism. EULAR Tool-box for patients outcomes. [cited 2017 Dec 2]. Available from: http://oml.eular.org/
   Google Scholar
• Boers M, Kirwan JR, Gossec L, et al. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0. J Rheumatol. 2014;41:1025–1030.
   PubMed Web of Science ®Google Scholar
• Castrejón I, Gossec L, Carmona L. The EULAR outcome measures library: an evolutional database of validated patient-reported instruments. Ann Rheum Dis. 2015;74:475–476.
   PubMed Web of Science ®Google Scholar
• Wells G, Li T, Maxwell L, et al. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis. 2008;67:260–265.
   PubMed Web of Science ®Google Scholar
• Højgaard P, Klokker L, Orbai AM, et al. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative. Semin Arthritis Rheum. 2017;9. pii: S0049-0172(17)30182-8.
   Google Scholar
• Ware JE, Sherbourne CD. The RAND 36 short-form health status survey: conceptual framework and item selection. Med Care. 1992;30:473–481.
   PubMed Web of Science ®Google Scholar
• Husted JA, Gladman DD, Farewell VT, et al. Validating the SF-36 health questionnaire in patients with psoriatic arthritis. J Rheumatol. 1997;24:511–517.
   PubMed Web of Science ®Google Scholar
• Leung YY, Ho KW, Zhu TY, et al. Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis. Rheumatology (Oxford). 2010;49:1495–1501.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Mease PJ. Measures of psoriatic arthritis: tender and swollen joint assessment, psoriasis area and severity index (PASI), nail psoriasis severity index (NAPSI), modified nail psoriasis severity index (mNAPSI), Mander/Newcastle enthesitis index (MEI), Leeds enthesitis index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht ankylosing spondylitis enthesis score (MASES), Leeds dactylitis index (LDI), patient global for psoriatic arthritis, dermatology life quality index (DLQI), psoriatic arthritis quality of life (PsAQOL), functional assessment of chronic illness therapy-fatigue (FACIT-F), psoriatic arthritis response criteria (PsARC), psoriatic arthritis joint activity index (PsAJAI), disease activity in psoriatic arthritis (DAPSA), and composite psoriatic disease activity index (CPDAI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S64–85.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Kimball AB, Krueger GG, et al. Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial. J Am Acad Dermatol. 2005;53:887–889.
   PubMed Web of Science ®Google Scholar
• EULAR Tools and products. [cited 2017 Dec 2]. Available from: http://www.eular.org/tools_products_.cfm
   Google Scholar
• de Wit M, Kvien T, Gossec L. Patient participation as an integral part of patient reported outcomes development guarantees the representativeness of the patient voice – a case-study from the field of rheumatology. RMD Open. 2015;1(1):e000129.
   PubMed Web of Science ®Google Scholar
• Di Carlo M, Becciolini A, Lato V, et al. The 12-item psoriatic arthritis impact of disease questionnaire: construct validity, reliability, and interpretability in a clinical setting. J Rheumatol. 2017;44:279–285.
   PubMed Web of Science ®Google Scholar
• Holland R, Tillett W, Korendowych E, et al. Validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire and its potential as a single-item outcome measure in clinical practice. Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211996. DOI:10.1136/annrheumdis-2017-211996 [Epub ahead of print].
   PubMedGoogle Scholar
• Salaffi F, Di Carlo M, Carotti M, et al. The psoriatic arthritis impact of disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version. Ther Clin Risk Manag. 2016;12:631–642.
   PubMed Web of Science ®Google Scholar
• Healy PJ, Helliwell PS. Psoriatic arthritis quality of life instrument: an assessment of sensitivity and response to change. J Rheumatol. 2008;35:1359–1361.
   PubMed Web of Science ®Google Scholar
• Taccari E, Spadaro A, Rinaldi T, et al. Comparison of the health assessment questionnaire and arthritis impact measurement scale in patients with psoriatic arthritis. Rev Rhum Engl Ed. 1998;65:751–758.
   PubMedGoogle Scholar
• Coaccioli S, Bruno AA, Celi G, et al. Validation of an original questionnaire for patients with psoriatic arthritis: the Psoriatic Arthritis Impact Profile (PAIP). Clin Ter. 2014;165:e100–e108.
   PubMedGoogle Scholar
• Chiricozzi A, Bianchi L, Zangrilli A, et al. Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PSOdisk. Eur J Dermatol. 2015;25:64–69.
   PubMed Web of Science ®Google Scholar
• El MY, El GM, Youssef SS, et al. Incorporating patient reported outcome measures in clinical practice: development and validation of a questionnaire for inflammatory arthritis. Clin Exp Rheumatol. 2010;28:734–744.
   PubMed Web of Science ®Google Scholar
• Cohen JM, Halim K, Joyce CJ, et al. Shedding light on the “Hidden Psoriasis”: A pilot study of the Inverse Psoriasis Burden of Disease (IPBOD) questionnaire. J Drugs Dermatol. 2016;15:1011–1016.
   PubMed Web of Science ®Google Scholar
• Leung YY, Thumboo J. Fibromyalgia as a contextual factor influencing disease activity measurements in spondyloarthritis and psoriatic arthritis. J Rheumatol. 2016;43:1953–1955.
   PubMed Web of Science ®Google Scholar
• Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75:499–510.
   PubMed Web of Science ®Google Scholar
• Stoffer MA, Smolen JS, Woolf A, et al. Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net. Project Ann Rheum Dis. 2014;73:902–905.
   PubMed Web of Science ®Google Scholar
• Patient-Centered Outcomes Research Institute. [cited 2017 Dec 2]. Available from: http://www.pcori.org/
   Google Scholar
• Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492–509.
   PubMed Web of Science ®Google Scholar
• Sanderson TC, Hewlett SE, Flurey C, et al. The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases. J Rheumatol. 2011;38:191–194.
   PubMed Web of Science ®Google Scholar
• Staley K. Summary exploring impact: public involvement in NHS. In Eastleigh: public health and social care research. INVOLVE. 2009.
   Google Scholar